Document is current
Any future updates will be listed below
-
Authors
Demircan, Kamil
Bengtsson, Ylva
Chillon, Thilo Samson
Vallon-Christersson, Johan
Sun, Qian
Larsson, Christer
Malmberg, Martin
Saal, Lao H.
Rydén, Lisa
Borg, Åke
Manjer, Jonas https://orcid.org/0000-0002-3158-5289
Schomburg, Lutz https://orcid.org/0000-0001-9445-1555
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Research Unit FOR-2558 “TraceAge” (Scho 849/6–2), CRC/TR 296 “Local control of TH action” (LocoTact, P17))
Fru Berta Kamprads Stiftelse
Berlin Institute of Health (Scholarship)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 16 June 2023
Accepted: 3 September 2023
First Online: 23 September 2023
Declarations
:
: The study was approved by the Regional Ethics Review Board of Lund at Lund University (diary numbers 2007/155, 2009/658, 2009/659, 2010/383, 2012/58, 2013/459) and registered under the ClinicalTrials.gov ID NCT02306096. All participants gave written consent to participate in the study.
: All authors have approved the manuscript for submission.
: LS holds shares of selenOmed GmbH, a company involved in selenium status measurement. The remaining authors have no competing interests to declare.
